Guidance when Developing Therapeutic Regimens for the Eradication of Helicobacter pylori in GI diseases

The purpose of this document is to suggest elements for consideration when designing clinical trials dealing with eradication of H. pylori in GI diseases and to outline elements to be reviewed in the submissions. It expands on the design of clinical trials when patients with active duodenal ulcers are included as subjects in clinical trials. For other Hp associated GI diseases, the guide provides elements to be considered in the study design.

Données et ressources

Info additionnelle

Champ	Valeur
Dernière modification	avril 17, 2026, 17:27 (TU)
Créé le	avril 17, 2026, 17:27 (TU)
criticality_level	[]
geographic_scope	[]
open_canada_collection	publication
open_canada_date_published	2010-02-12 00:00:00
open_canada_keywords	{"fr": ["Orientation", "développement de schémas thérapeutiques", "éradication", "éradication de Helicobacter pylori", "maladies gastro-intestinales"], "en": ["Guidance", "developing therapeutic regimens", "eradication", "eradication of helicobacter pylori", "GI diseases"]}
open_canada_subject	["health_and_safety"]
sensitivity_level	unrestricted
title_fr	Guide pour le développement des régimes thérapeutiques visant à éradiquer Helicobacter pylori dans les maladies gastro-intestinales
update_frequency	as_needed